Felix Oden has an extensive background in oncology and radiopharmacology, currently serving as a Senior Principal Scientist in R&D Oncology and Lab Head of Targeted Alpha Therapies at Bayer since June 2024. Prior to this role, Felix contributed as a Scientist in R&D at Life Molecular Imaging from August 2018 to August 2021. Felix also gained valuable experience as a Postdoc in Radiopharmacology and Scientist in R&D at PIRAMAL IMAGING from June 2014 to March 2016. Earlier, Felix worked as a Wissenschaftlicher Mitarbeiter (Postdoktorand) at the Max Delbrück Center for Molecular Medicine in early 2014, focusing on the structure and membrane interaction of G-Proteins.
This person is not in the org chart
This person is not in any teams
This person is not in any offices